Dr Paul Joseph Schonbrun, DO - Medicare Emergency Medicine in Fort Polk, LA

Dr Paul Joseph Schonbrun, DO is a medicare enrolled "Emergency Medicine" physician in Fort Polk, Louisiana. His current practice location is 1585 3rd St, Emergency Department, Fort Polk, Louisiana. You can reach out to his office (for appointments etc.) via phone at (337) 531-3368.

Dr Paul Joseph Schonbrun is licensed to practice in New York (license number 195593) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1790903292.

Contact Information

Dr Paul Joseph Schonbrun, DO
1585 3rd St, Emergency Department,
Fort Polk, LA 71459-5102
(337) 531-3368
Not Available



Physician's Profile

Full NameDr Paul Joseph Schonbrun
GenderMale
SpecialityEmergency Medicine
Location1585 3rd St, Fort Polk, Louisiana
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1790903292
  • Provider Enumeration Date: 04/23/2007
  • Last Update Date: 10/15/2012
  Medicare PECOS Information:
  • PECOS PAC ID: 6103857339
  • Enrollment ID: I20140623002274

Medical Identifiers

Medical identifiers for Dr Paul Joseph Schonbrun such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1790903292NPI-NPPES
195593OtherNYNYS LICENSE
01541919MedicaidNY
1790903292OtherNYNPI

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207P00000XEmergency Medicine 195593 (New York)Primary
207P00000XEmergency Medicine DO.00197 (Louisiana)Secondary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Paul Joseph Schonbrun allows following entities to bill medicare on his behalf.
Entity NameCorrect Care, Inc.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1215987441
PECOS PAC ID: 8628980992
Enrollment ID: O20040816000150

News Archive

Repurposing leukemia drugs may be effective approach for treating metastatic melanoma patients

Data from a new study led by University of Kentucky Markey Cancer Center researchers shows that repurposing drugs used to treat leukemia has promise for preventing melanoma metastasis.

Bacterial infections may trigger dysregulation of blood formation

It has been thought that only immune cells would act as the line of defense during bacterial infection. However, recent research has revealed that hematopoietic stem cells, cells that create all other blood cells throughout an individual's lifetime, are also able to respond to the infection.

Pakistani refugees continue to be at high risk for disease, U.N. says

The 2 million Pakistani refugees forced from their homes due to a military offensive against Taliban militants in the northwestern Swat Valley continue to be at high risk for diseases "as they cope with damaged water and sewage systems in towns and villages," according to the U.N., Bloomberg reports.

Biomedical researchers successfully convert microbubble technology into nanoparticles

Biomedical researchers led by Dr. Gang Zheng at Princess Margaret Cancer Centre have successfully converted microbubble technology already used in diagnostic imaging into nanoparticles that stay trapped in tumours to potentially deliver targeted, therapeutic payloads.

Read more Medical News

› Verified 5 days ago

Entity NameEmergency Staffing Solutions Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1477590974
PECOS PAC ID: 9830001650
Enrollment ID: O20050610000177

News Archive

Repurposing leukemia drugs may be effective approach for treating metastatic melanoma patients

Data from a new study led by University of Kentucky Markey Cancer Center researchers shows that repurposing drugs used to treat leukemia has promise for preventing melanoma metastasis.

Bacterial infections may trigger dysregulation of blood formation

It has been thought that only immune cells would act as the line of defense during bacterial infection. However, recent research has revealed that hematopoietic stem cells, cells that create all other blood cells throughout an individual's lifetime, are also able to respond to the infection.

Pakistani refugees continue to be at high risk for disease, U.N. says

The 2 million Pakistani refugees forced from their homes due to a military offensive against Taliban militants in the northwestern Swat Valley continue to be at high risk for diseases "as they cope with damaged water and sewage systems in towns and villages," according to the U.N., Bloomberg reports.

Biomedical researchers successfully convert microbubble technology into nanoparticles

Biomedical researchers led by Dr. Gang Zheng at Princess Margaret Cancer Centre have successfully converted microbubble technology already used in diagnostic imaging into nanoparticles that stay trapped in tumours to potentially deliver targeted, therapeutic payloads.

Read more Medical News

› Verified 5 days ago

Entity NameRapid Urgent Care Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1285970780
PECOS PAC ID: 0840437174
Enrollment ID: O20130506000203

News Archive

Repurposing leukemia drugs may be effective approach for treating metastatic melanoma patients

Data from a new study led by University of Kentucky Markey Cancer Center researchers shows that repurposing drugs used to treat leukemia has promise for preventing melanoma metastasis.

Bacterial infections may trigger dysregulation of blood formation

It has been thought that only immune cells would act as the line of defense during bacterial infection. However, recent research has revealed that hematopoietic stem cells, cells that create all other blood cells throughout an individual's lifetime, are also able to respond to the infection.

Pakistani refugees continue to be at high risk for disease, U.N. says

The 2 million Pakistani refugees forced from their homes due to a military offensive against Taliban militants in the northwestern Swat Valley continue to be at high risk for diseases "as they cope with damaged water and sewage systems in towns and villages," according to the U.N., Bloomberg reports.

Biomedical researchers successfully convert microbubble technology into nanoparticles

Biomedical researchers led by Dr. Gang Zheng at Princess Margaret Cancer Centre have successfully converted microbubble technology already used in diagnostic imaging into nanoparticles that stay trapped in tumours to potentially deliver targeted, therapeutic payloads.

Read more Medical News

› Verified 5 days ago

Entity NameEss Hospitalist Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1881967305
PECOS PAC ID: 6103085295
Enrollment ID: O20130515000072

News Archive

Repurposing leukemia drugs may be effective approach for treating metastatic melanoma patients

Data from a new study led by University of Kentucky Markey Cancer Center researchers shows that repurposing drugs used to treat leukemia has promise for preventing melanoma metastasis.

Bacterial infections may trigger dysregulation of blood formation

It has been thought that only immune cells would act as the line of defense during bacterial infection. However, recent research has revealed that hematopoietic stem cells, cells that create all other blood cells throughout an individual's lifetime, are also able to respond to the infection.

Pakistani refugees continue to be at high risk for disease, U.N. says

The 2 million Pakistani refugees forced from their homes due to a military offensive against Taliban militants in the northwestern Swat Valley continue to be at high risk for diseases "as they cope with damaged water and sewage systems in towns and villages," according to the U.N., Bloomberg reports.

Biomedical researchers successfully convert microbubble technology into nanoparticles

Biomedical researchers led by Dr. Gang Zheng at Princess Margaret Cancer Centre have successfully converted microbubble technology already used in diagnostic imaging into nanoparticles that stay trapped in tumours to potentially deliver targeted, therapeutic payloads.

Read more Medical News

› Verified 5 days ago

Entity NameJena Ess Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1235544115
PECOS PAC ID: 7810116258
Enrollment ID: O20140916002675

News Archive

Repurposing leukemia drugs may be effective approach for treating metastatic melanoma patients

Data from a new study led by University of Kentucky Markey Cancer Center researchers shows that repurposing drugs used to treat leukemia has promise for preventing melanoma metastasis.

Bacterial infections may trigger dysregulation of blood formation

It has been thought that only immune cells would act as the line of defense during bacterial infection. However, recent research has revealed that hematopoietic stem cells, cells that create all other blood cells throughout an individual's lifetime, are also able to respond to the infection.

Pakistani refugees continue to be at high risk for disease, U.N. says

The 2 million Pakistani refugees forced from their homes due to a military offensive against Taliban militants in the northwestern Swat Valley continue to be at high risk for diseases "as they cope with damaged water and sewage systems in towns and villages," according to the U.N., Bloomberg reports.

Biomedical researchers successfully convert microbubble technology into nanoparticles

Biomedical researchers led by Dr. Gang Zheng at Princess Margaret Cancer Centre have successfully converted microbubble technology already used in diagnostic imaging into nanoparticles that stay trapped in tumours to potentially deliver targeted, therapeutic payloads.

Read more Medical News

› Verified 5 days ago

Entity NameJena Ess Hospitalist Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1144635020
PECOS PAC ID: 5294954533
Enrollment ID: O20140918000317

News Archive

Repurposing leukemia drugs may be effective approach for treating metastatic melanoma patients

Data from a new study led by University of Kentucky Markey Cancer Center researchers shows that repurposing drugs used to treat leukemia has promise for preventing melanoma metastasis.

Bacterial infections may trigger dysregulation of blood formation

It has been thought that only immune cells would act as the line of defense during bacterial infection. However, recent research has revealed that hematopoietic stem cells, cells that create all other blood cells throughout an individual's lifetime, are also able to respond to the infection.

Pakistani refugees continue to be at high risk for disease, U.N. says

The 2 million Pakistani refugees forced from their homes due to a military offensive against Taliban militants in the northwestern Swat Valley continue to be at high risk for diseases "as they cope with damaged water and sewage systems in towns and villages," according to the U.N., Bloomberg reports.

Biomedical researchers successfully convert microbubble technology into nanoparticles

Biomedical researchers led by Dr. Gang Zheng at Princess Margaret Cancer Centre have successfully converted microbubble technology already used in diagnostic imaging into nanoparticles that stay trapped in tumours to potentially deliver targeted, therapeutic payloads.

Read more Medical News

› Verified 5 days ago

Entity NameConcord Medical Group Pllc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1083630610
PECOS PAC ID: 0446296818
Enrollment ID: O20140930001176

News Archive

Repurposing leukemia drugs may be effective approach for treating metastatic melanoma patients

Data from a new study led by University of Kentucky Markey Cancer Center researchers shows that repurposing drugs used to treat leukemia has promise for preventing melanoma metastasis.

Bacterial infections may trigger dysregulation of blood formation

It has been thought that only immune cells would act as the line of defense during bacterial infection. However, recent research has revealed that hematopoietic stem cells, cells that create all other blood cells throughout an individual's lifetime, are also able to respond to the infection.

Pakistani refugees continue to be at high risk for disease, U.N. says

The 2 million Pakistani refugees forced from their homes due to a military offensive against Taliban militants in the northwestern Swat Valley continue to be at high risk for diseases "as they cope with damaged water and sewage systems in towns and villages," according to the U.N., Bloomberg reports.

Biomedical researchers successfully convert microbubble technology into nanoparticles

Biomedical researchers led by Dr. Gang Zheng at Princess Margaret Cancer Centre have successfully converted microbubble technology already used in diagnostic imaging into nanoparticles that stay trapped in tumours to potentially deliver targeted, therapeutic payloads.

Read more Medical News

› Verified 5 days ago

Entity NameOakdale Ess Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1750785119
PECOS PAC ID: 7517289713
Enrollment ID: O20141125000402

News Archive

Repurposing leukemia drugs may be effective approach for treating metastatic melanoma patients

Data from a new study led by University of Kentucky Markey Cancer Center researchers shows that repurposing drugs used to treat leukemia has promise for preventing melanoma metastasis.

Bacterial infections may trigger dysregulation of blood formation

It has been thought that only immune cells would act as the line of defense during bacterial infection. However, recent research has revealed that hematopoietic stem cells, cells that create all other blood cells throughout an individual's lifetime, are also able to respond to the infection.

Pakistani refugees continue to be at high risk for disease, U.N. says

The 2 million Pakistani refugees forced from their homes due to a military offensive against Taliban militants in the northwestern Swat Valley continue to be at high risk for diseases "as they cope with damaged water and sewage systems in towns and villages," according to the U.N., Bloomberg reports.

Biomedical researchers successfully convert microbubble technology into nanoparticles

Biomedical researchers led by Dr. Gang Zheng at Princess Margaret Cancer Centre have successfully converted microbubble technology already used in diagnostic imaging into nanoparticles that stay trapped in tumours to potentially deliver targeted, therapeutic payloads.

Read more Medical News

› Verified 5 days ago

Entity NameConcord North Texas Pllc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1952761173
PECOS PAC ID: 2860791688
Enrollment ID: O20170922000452

News Archive

Repurposing leukemia drugs may be effective approach for treating metastatic melanoma patients

Data from a new study led by University of Kentucky Markey Cancer Center researchers shows that repurposing drugs used to treat leukemia has promise for preventing melanoma metastasis.

Bacterial infections may trigger dysregulation of blood formation

It has been thought that only immune cells would act as the line of defense during bacterial infection. However, recent research has revealed that hematopoietic stem cells, cells that create all other blood cells throughout an individual's lifetime, are also able to respond to the infection.

Pakistani refugees continue to be at high risk for disease, U.N. says

The 2 million Pakistani refugees forced from their homes due to a military offensive against Taliban militants in the northwestern Swat Valley continue to be at high risk for diseases "as they cope with damaged water and sewage systems in towns and villages," according to the U.N., Bloomberg reports.

Biomedical researchers successfully convert microbubble technology into nanoparticles

Biomedical researchers led by Dr. Gang Zheng at Princess Margaret Cancer Centre have successfully converted microbubble technology already used in diagnostic imaging into nanoparticles that stay trapped in tumours to potentially deliver targeted, therapeutic payloads.

Read more Medical News

› Verified 5 days ago

Entity NameHodges Emergency Group Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1710441316
PECOS PAC ID: 2567703978
Enrollment ID: O20190412000898

News Archive

Repurposing leukemia drugs may be effective approach for treating metastatic melanoma patients

Data from a new study led by University of Kentucky Markey Cancer Center researchers shows that repurposing drugs used to treat leukemia has promise for preventing melanoma metastasis.

Bacterial infections may trigger dysregulation of blood formation

It has been thought that only immune cells would act as the line of defense during bacterial infection. However, recent research has revealed that hematopoietic stem cells, cells that create all other blood cells throughout an individual's lifetime, are also able to respond to the infection.

Pakistani refugees continue to be at high risk for disease, U.N. says

The 2 million Pakistani refugees forced from their homes due to a military offensive against Taliban militants in the northwestern Swat Valley continue to be at high risk for diseases "as they cope with damaged water and sewage systems in towns and villages," according to the U.N., Bloomberg reports.

Biomedical researchers successfully convert microbubble technology into nanoparticles

Biomedical researchers led by Dr. Gang Zheng at Princess Margaret Cancer Centre have successfully converted microbubble technology already used in diagnostic imaging into nanoparticles that stay trapped in tumours to potentially deliver targeted, therapeutic payloads.

Read more Medical News

› Verified 5 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Paul Joseph Schonbrun is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Paul Joseph Schonbrun, DO
224 George Drive,
Deridder, LA 70634-6053

Ph: (845) 399-0034
Dr Paul Joseph Schonbrun, DO
1585 3rd St, Emergency Department,
Fort Polk, LA 71459-5102

Ph: (337) 531-3368

News Archive

Repurposing leukemia drugs may be effective approach for treating metastatic melanoma patients

Data from a new study led by University of Kentucky Markey Cancer Center researchers shows that repurposing drugs used to treat leukemia has promise for preventing melanoma metastasis.

Bacterial infections may trigger dysregulation of blood formation

It has been thought that only immune cells would act as the line of defense during bacterial infection. However, recent research has revealed that hematopoietic stem cells, cells that create all other blood cells throughout an individual's lifetime, are also able to respond to the infection.

Pakistani refugees continue to be at high risk for disease, U.N. says

The 2 million Pakistani refugees forced from their homes due to a military offensive against Taliban militants in the northwestern Swat Valley continue to be at high risk for diseases "as they cope with damaged water and sewage systems in towns and villages," according to the U.N., Bloomberg reports.

Biomedical researchers successfully convert microbubble technology into nanoparticles

Biomedical researchers led by Dr. Gang Zheng at Princess Margaret Cancer Centre have successfully converted microbubble technology already used in diagnostic imaging into nanoparticles that stay trapped in tumours to potentially deliver targeted, therapeutic payloads.

Read more News

› Verified 5 days ago


Emergency Medicine Doctors in Fort Polk, LA

Gerard Tiffault, MD
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 1585 3rd St, Fort Polk, LA 71459
Phone: 240-351-9565    
Celeste A Lujan, MD
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 1585 3rd St, Building 285, Fort Polk, LA 71459
Phone: 337-531-2008    
Stephen Brooke Cox, MD
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1585 3rd St, Fort Polk, LA 71459
Phone: 337-531-3011    
Victor M. Camacho, M.D.
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 1585 3rd St, Fort Polk, LA 71459
Phone: 337-531-3701    
Dr. Laurel Ashlin Thurston, MD
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1585 3rd St, Fort Polk, LA 71459
Phone: 337-531-3368    
Dr. Dane Hamilton Nerad, DO
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1585 3rd St, Fort Polk, LA 71459
Phone: 337-531-3011    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.